NRX Pharmaceuticals, Inc. Common Stock
NRXP •
Buy Open
Signal type
Buy
Status
Open
Open Price
$2.49
Stop Loss
$1.91
Performance
0.40%
Days Open
21
Signal Setup
Signal Type Buy
Status Open
Open Date Mar 25, 2026
Open Price $2.49
Stop Loss $1.91
Timespan Day
Company Profile
Name NRX Pharmaceuticals, Inc. Common Stock
Ticker NRXP
Market Cap $63.58M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $2.50
List Date May 25, 2021
Description
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Website Open Company Website